Literature DB >> 20848640

An aggressive systemic juvenile xanthogranuloma clonally related to a preceding T-cell acute lymphoblastic leukemia.

Ruy Perez-Becker1, Monika Szczepanowski, Ivo Leuschner, Gritta Janka, Michael Gokel, Thomas Imschweiler, Sigrid Völpel, Tim Niehues, Wolfram Klapper.   

Abstract

Juvenile xanthogranuloma (JXG) is a disorder of disputed origin thought to be related to the dermal/interstitial macrophage. A 5-year-old female presented with an aggressive systemic JXG that developed 5 months after the diagnosis of T-cell acute lymphoblastic leukemia (T-ALL). Examination of the T-cell receptor gamma (TCR-γ) rearrangement in T-ALL blasts, JXG infiltrated lymph node biopsies and micro-dissected JXG histiocytes revealed an identical bi-allelic TCR-γ rearrangement in all samples, thus providing evidence for a clonal relationship between T-ALL and JXG in this case.
Copyright © 2011 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20848640     DOI: 10.1002/pbc.22756

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  3 in total

Review 1.  [Histiocytic diseases in childhood and adolescence].

Authors:  C Vokuhl; I Oschlies; W Klapper; I Leuschner
Journal:  Pathologe       Date:  2015-09       Impact factor: 1.011

Review 2.  Fatal juvenile xanthogranuloma presenting as a sellar lesion: case report and literature review.

Authors:  Sherise D Ferguson; Steven G Waguespack; Lauren A Langford; Joann L Ater; Ian E McCutcheon
Journal:  Childs Nerv Syst       Date:  2014-12-12       Impact factor: 1.475

3.  Disseminated Juvenile Xanthogranuloma and Hemophagocytic Lymphohistiocytosis Developed During Treatment of Acute Lymphoblastic Leukemia: Case Report.

Authors:  Katarzyna Pawińska-Wa Sikowska; Magdalena Cwiklinska; Elzbieta Wyrobek; Walentyna Balwierz; Karolina Bukowska-Strakova; Agnieszka Dluzniewska; Jolanta Gozdzik; Grazyna Drabik; Monika Rygielska; Konrad Stepien; Szymon Skoczen
Journal:  Front Oncol       Date:  2020-07-03       Impact factor: 6.244

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.